The rate of thyroid cancer appears to be on the rise, and our Otolaryngologists
work together to provide patients with a multidisciplinary approach to care for patients with thyroid problems. These physicians have recently introduced genetic-based testing that can help determine whether nodules are benign or cancerous. The first step to evaluate concerning nodules is fine needle aspiration, but one third of aspiration samples are unable to provide a clear diagnosis. Historically, all patients with such “indeterminate” biopsy results were advised to undergo thyroid surgery for definitive evaluation.
However, the new genetic-based test is able to classify more than half of these “indeterminate” nodules as benign, eliminating the need for surgery. Additional new genetic tests on the horizon can provide even more detail, helping physicians determine the best treatment for each individual patient.